Story of Chugai
Stories
A Story of Paving the Way to the Future,
Thinking
of Patients' Happiness
So many people around the world still suffer from diseases that have no cure.
Chugai aims to deliver effective treatments and services through the power of innovation, with the goal of bringing happiness to patients.
To achieve this, each employee pursues the creation of continuous innovation with fresh ideas that are not bound by conventional wisdom.
Realizing advanced and sustainable patient-centric healthcare.
We present to you the story of our employees' challenges as they forge ahead on uncharted paths, always keeping in mind the happiness of patients that lies beyond.
PICK UP
Jul 08, 2026
Chugai is advancing its efforts to realize personalized medicine—delivering optimal treatment tailored to each individual patient—by exploring not
- DX
Display Conditions
-
Taking on the Challenge of “Co-Creation” and “Personalized Medicine”: An Interview with Chugai’s SaMD Development Team
Chugai is advancing its efforts to realize personalized medicine—delivering optimal treatment tailored to each individual patient—by exploring not
- DX
-
Chugai Pharmaceutical × Roche Diagnostics toward deeper Co‑Creation beyond corporate boundaries— Uniting Pharmaceuticals and Diagnostics
Chugai Pharmaceutical Co., Ltd. and Roche Diagnostics K.K. (hereinafter “RDKK”)—two companies active in different fields, pharmaceuticals and
- DX
- Event
-
Creating New Forms of Patient Contribution Through Real‑World Data: How the Drug Safety Division Is Leading the Way
Chugai Pharmaceutical is promoting the company-wide use of real-world data (RWD)*¹. In this article, we focus in particular on project members from the
- R&D
- DX
- Sustainable Healthcare
-
Carrying Patient Voices Into the Future: Japan’s Bleeding Disorders Registry
Delivering optimal care even for rare diseases — driven by this commitment, patient advocacy groups, an academic society, and a pharmaceutical company
- Disease Awareness
- Sustainable Healthcare
-
Pharmaceutical Development Accelerated with Real-world data (RWD) - Taking on the Challenge of Developing Acute-phase Therapeutic Drugs in Collaboration with MeDiCU, Inc.
Chugai Pharmaceutical utilizes real-world data (RWD)* for increased efficiency and advancement in the clinical development of new drugs, verification of drug
- R&D
- DX
- External Experts
-
Transforming Bioprocesses Through the Use of AI: A Challenge Driven by Collaboration Between Data Scientists and Bioprocess Researchers
Bioprocessing is a method of producing active pharmaceutical ingredients for biopharmaceuticals using living cells and microorganisms, and it plays a critically
- Innovation
- R&D
- DX
-
CHUGAI INNOVATION DAY 2024 Report—More Than 3,000 in Attendance
Chugai Pharmaceutical’s CHUGAI INNOVATION DAY 2024 was hosted on November 25 (Mon) and 26 (Tue), 2024. This was the fifth hosting of the CHUGAI INNOVATION
- Innovation
- R&D
- DX
- Event
-
Working Toward Greater Efficiency in the Drug Discovery Process for Macrocyclic Peptides. Development of a Crystallization Confirmation App Using Agile Development Methods
Agile development has recently been garnering attention as a method that involves quickly ascertaining needs and progressing with a project in an agile and
- Innovation
- R&D
- DX
- Macrocyclic Peptide Drugs
-
Next-generation pharmaceutical lead by digital technology Taking on innovative drug development with a data-driven approach
The Pharmaceutical Technology Division is in charge of the development process leading to the commercialization of candidate molecules. Within that division,
- R&D
- DX
- Recruitment
- Research
- Drug Discovery Modalities
- Production Technology
-
Takao Suzuki was previously an employee at Microsoft where he supported numerous companies as director of the DX strategy advisory department. He now works as Head of the DX Unit at Chugai Pharmaceutical. According to Suzuki, what are the key factors to ensuring the successful implementation of DX?
Aiming to become the top innovator in the healthcare industry, Chugai Pharmaceutical has positioned DX as a fundamental element of its growth strategy. Phase 1
- Innovation
- DX
- CHUGAI DIGITAL VISION 2030
- Top Interview
-
Greater Efficiency in Bioprocess Development. Digital Transformations in Pharmaceuticals
Chugai Pharmaceutical is currently promoting companywide DX to achieve the targets of its new growth strategy Top I 2030. The company is focusing on innovative
- Innovation
- R&D
- DX
- Sustainability
- CHUGAI DIGITAL VISION 2030
- Production Technology
-
Supporting the transformation of business with global-standard systems infrastructure. Stories from behind the scenes of the ERP system renewal project and the sense of reward that it gives, as discussed by staff working on the next-generation core business (ERP) system
With the promotion of DX, expectations are growing for the appropriate use of information about companies’ management resources. At Chugai Pharmaceutical
- R&D
- DX
- Recruitment
- IT Infrastructure
-
Supporting DX with substantive risk management. To take the lead in cybersecurity to realize word-class drug discovery
Concurrently with its promotion of digital transformation (DX), Chugai Pharmaceutical is strengthening cybersecurity measures for the entire Group, including
- DX
- Recruitment
- Supply Chain Management
- Cybersecurity
-
Maximizing Drug Discovery Through Team Capabilities. Delivering Innovative Drugs to Patients with Process and Technological Development
Kondo is an employee at the pharmaceutical research department. Within his group, in addition to overseeing process development and manufacturing technology
- Innovation
- R&D
- DX
- Recruitment
- Macrocyclic Peptide Drugs
- Production Technology
-
Accelerating DX with open innovation. The future of healthcare aimed for through company-wide awareness reform
Yanaizu belongs to the Digital Strategy Department which leads Chugai Pharmaceutical’s digital transformation (DX). Since joining the company in 2023, she
- R&D
- DX
- Partnering
- Recruitment
- CHUGAI DIGITAL VISION 2030